Identification of a novel plasmid-mediated β-lactamase with chromosomal cephalosporinase characteristics from klebsiella pneumoniae

Journal of Antimicrobial Chemotherapy

Volumn 31, Issue 5, 1993, Pages 645-654

  Tzouvelekis, L S ^a   Tzelepi, E ^a   Mentis, A F ^a   Tsakris, A ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE; CEFALEXIN; CEFALORIDINE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CEPHAMYCIN DERIVATIVE; CLAVULANIC ACID; CLOXACILLIN; PENICILLIN DERIVATIVE; SULBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ESCHERICHIA COLI; HYDROLYSIS; ISOELECTRIC POINT; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; R PLASMID;

ANTIBIOTICS, COMBINED; ANTIBIOTICS, LACTAM; BETA-LACTAMASES; CEPHALOSPORINASE; CHROMOSOMES, BACTERIAL; CLAVULANIC ACID; CLAVULANIC ACIDS; DRUG RESISTANCE, MICROBIAL; ISOELECTRIC FOCUSING; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PENICILLINASE; PLASMIDS; SULBACTAM; SUPPORT, NON-U.S. GOV'T;

EID: 0027273315     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/31.5.645     Document Type: Article

References (23)

1. Bauerfeind, A., Chong, Y. and Schweighart, S. (1989). Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 17, 316-21.
2. Bernard, H., Tancrede, C, Livrelli, V., Morand, A., Barthelelemy, M. and Labia, R. (1992). A novel plasmid-mediated extended-spectrum β-lactamase not derived from TEM- or SHV-type enzymes. Journal of Antimicrobial Chemotherapy 29, 590-2.
3. Greek Society for Microbiology. (1989). Antibiotic resistance among Gram-negative bacilli in 19 Greek hospitals. Journal of Hospital Infection 14, 169-71.
4. Honore, N., Nicolas, M.-H. and Cole, S. T. (1986). Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli. EM BO Journal 5, 3709-14.
5. Jarlier, V., Nicolas, M.-H., Fournier, G. and Philippon, A. (1988). Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Disease 10, 867-78.
6. Jacoby, G. A. and Carreras, I. (1990). Activities of β-lactam antibiotics against Escherichia coli strains producing extended spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 34, 858-62.
7. Kontomichalou, P., Mitani, M. and Clowes, R. C. (1970). Circular R factor molecules controlling penicillinase synthesis replicating in Escherichia coli under either relaxed or stringent control. Journal of Bacteriology 104, 33-44.
8. Labia, R., Mozand, A., Tiwazi, K., Sirot, J., Sirot, D. and Petit, A. (1988). Interactions of new plasmid-mediated β-lactamases with third-generation cephalosporins. Reviews of Infectious Diseases 10, 885-91.
9. Martinez, J. L., Vincente, M. F., Delgado-Iribarren, A., Perez-Diaz, J. C. and Baquero, F. (1989). Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy 33, 595.
10. Matthew, M., Harris, A. M., Marshall, M. J. and Ross, G. W. (1975). The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88, 169-78.
11. O’Callaghan, C. H., Muggleton, P. W. and Ross, G. W. (1969). Effects of β-lactamases from Gram-negative organisms on cephalosporins and penicillins. In Antimicrobial Agents and Chemotherapy-1968 (Hobby, G. L., Ed.), pp. 57-63. American Society for Microbiology, Bethesda, MD.
12. Olsen, J. E. (1990). An improved method for rapid isolation of plasmid DNA from wild-type Gram-negative bacteria for plasmid restriction profile analysis. Letters in Applied Microbiology 10, 209-12.
13. Page, J. W. J., Farmer, T. H. and Elson, S. W. (1989). Hyperproduction of TEM-1 β-lactamase by Escherichia coli strains. Journal of Antimicrobial Chemotherapy 23, 160-1.
14. Papanicolaou, G. A., Medeiros, A. A. and Jacoby, G. A. (1990). Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and a-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 34, 2200-9.
15. Payne, D. J. and Amyes, S. G. B. (1991). Transferable resistance to extended spectrum β-lactams: a major threat or a minor inconvenience? Journal of Antimicrobial Chemotherapy 27, 255-61.
16. Payne, D. J., Woodford, N. and Amyes, S. G. B. (1992). Characterization of the plasmid mediated β-lactamase BIL-1. Journal of Antimicrobial Chemotherapy 30, 119-27.
17. Peduzzi, J., Berthelemy, M., Tiwari, K., Mattioni, D. and Lazbia, R. (1989). Structural features related to hydrolytic activity against ceftazidime of plasmid mediated SHV-type CAZ-5 β-lactamase. Antimicrobial Agents and Chemotherapy 33, 2160-3.
18. Philippon, A., Labia, R. and Jacoby, G. (1989). Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 33, 1131-6.
19. Sambrook, J., Fritsch, E. F. and Maniatis, T. (1989). Molecular Cloning: a Laboratory Manual, 2nd end, 3 Vols. Cold Spring Harbor Press, Cold Spring Harbor, NY.
20. Sougakoff, W., Goussard, S., Gerbaud, G. and Courvalin, A. (1988). Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Reviews of Infectious Diseases 10, 879-84.
21. Vatopoulos, A. C., Philippon, A., Tzouvelekis, L. S., Komninou, Z. and Legakis, N. J. (1990). Prevalence of a transferable SHV-5 type β-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece. Journal of Antimicrobial Chemotherapy 26, 635-48.
22. Williams, H., King, A., Shannon, K. and Phillips, I. (1988). Amoxicillin/clavulanate resistant Escherichia coli. Lancet 1, 304-5.
23. Wu, S. W., Dornbusch, K., Norgren, M. and Kronvall, G. (1992). Extended spectrum β-lactamase from Klebsiella oxytoca, not belonging to the TEM or SHV family. Journal of Antimicrobial Chemotherapy 30, 3-16.